ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
VYNE Therapeutics Inc

VYNE Therapeutics Inc (VYNE)

3,03
0,13
(4,48%)
Geschlossen 23 November 10:00PM
3,1699
0,1399
(4,62%)
Nach Börsenschluss: 1:17AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
3,1699
Gebot
2,98
Fragen
3,18
Volumen
67.653
2,88 Tagesbereich 3,12
1,57 52-Wochen-Bereich 4,09
Marktkapitalisierung
Handelsende
2,90
Handelsbeginn
2,88
Letzter Handelszeitpunkt
Finanzvolumen
US$ 203.862
VWAP
3,0134
Durchschnittliches Volumen (3 Mio.)
80.409
Ausgegebene Aktien
14.751.433
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,57
Gewinn pro Aktie (EPS)
-1,93
Erlöse
424k
Nettogewinn
-28,45M

Über VYNE Therapeutics Inc

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate... VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
VYNE Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VYNE. The last closing price for VYNE Therapeutics was US$2,90. Over the last year, VYNE Therapeutics shares have traded in a share price range of US$ 1,57 to US$ 4,09.

VYNE Therapeutics currently has 14.751.433 shares in issue. The market capitalisation of VYNE Therapeutics is US$42,78 million. VYNE Therapeutics has a price to earnings ratio (PE ratio) of -1.57.

VYNE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.309910.83566433572.863.16992.65741072.78194663CS
40.499918.72284644192.673.382.571116802.94704777CS
121.379977.08938547491.793.381.73804092.52698659CS
260.479917.84014869892.693.381.57641672.29509147CS
52-0.8201-20.55388471183.994.091.57813462.39382425CS
156-16.9901-84.276289682520.1631.51.5756783711.69242847CS
260-103.3901-97.025243994106.56237.61.57108854595.29198095CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PDYNPalladyne AI Corporation
US$ 4,59
(129,50%)
83M
QMCOQuantum Corporation
US$ 9,11
(126,62%)
39,41M
NANano Labs Ltd
US$ 8,26
(89,02%)
2,03M
XCURExicure Inc
US$ 18,60
(71,27%)
4,36M
SKKSKK Holdings Limited
US$ 1,75
(59,09%)
95,06M
AMIXAutonomix Medical Inc
US$ 6,21
(-54,07%)
946,09k
CETXCemtrex Inc
US$ 0,1146
(-41,74%)
24,39M
MSWMing Shing Group Holdings Ltd
 5,90
(-35,52%)
417,08k
RMSGReal Messenger Corporation
US$ 3,09
(-26,25%)
313,51k
ENSCEnsysce Biosciences Inc
US$ 0,4414
(-25,49%)
4M
ELABElevai Labs Inc
US$ 0,0201
(-0,50%)
425,38M
NVDANVIDIA Corporation
US$ 141,95
(-3,22%)
236,51M
SMCISuper Micro Computer Inc
US$ 33,15
(11,62%)
159,61M
VRPXVirpax Pharmaceuticals Inc
US$ 0,5501
(-6,72%)
159,39M
SOUNSoundHound AI Inc
US$ 8,24
(18,05%)
107,91M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock